AUB
DFTX

Atlantic Union Bankshares’s Definium Therapeutics DFTX Stock Holding History

Atlantic Union Bankshares’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$6.7K – 1805
2025
Q4 		$6.7K Buy
+500
New +$6.19K ﹤0.01% 1340

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atlantic Union Bankshares's DFTX Position: Q1 2026 in Review

Atlantic Union Bankshares sold out of Definium Therapeutics (DFTX) in Q1 2026, closing a stake of 500 shares — an estimated $6.7K sold.

Atlantic Union Bankshares first reported a position in DFTX in Q4 2025 and held it in 1 quarter. The position peaked at $6.7K in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Atlantic Union Bankshares reported no remaining Definium Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Atlantic Union Bankshares sold 500 Definium Therapeutics shares in Q1 2026, an estimated $6.7K.
  • Atlantic Union Bankshares first reported a position in Definium Therapeutics in Q4 2025 and held it in 1 quarter.
  • Atlantic Union Bankshares's Definium Therapeutics position peaked at $6.7K in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.